Evgen Pharma PLC Upcoming Investor Presentations

Evgen Pharma PLC (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, has today announced that Dr Stephen Franklin, the Company’s CEO, will present at a series of upcoming investor evenings.

The presentation will focus on the Phase II trials of SFX-01, the Company’s lead product, in the treatment of breast cancer and subarachnoid haemorrhage, a type of stroke.

Investors and shareholders wishing to register for the investor presentations may do so through the links provided below.

16 May 2018 – ShareSoc Growth Company Seminar, London

Time: The presentation will start at 5.30pm followed by a buffet and refreshments.

Location: Link Asset Services, 65 Gresham Street, London, EC2V 7NQ.

Link to register: https://www.sharesoc.org/events/sharesoc-growth-company-seminar-in-london-16-may-2018/

17 May 2018 – Proactive Investors Healthcare, London

Time: The presentation will start at 6.00pm followed by drinks and canapés.

Location: Chesterfield Mayfair Hotel, 35 Charles Street, London, W1J 5EB.

Link to register: http://www.proactiveinvestors.co.uk/register/event_details/142

19 June 2018 – ShareSoc Growth Company Seminar, Manchester

Time: The presentation will start at 5.30pm followed by a buffet and refreshments.

Location: Kuits Solicitors, 7th Floor, Blackfriars House, Manchester, M3 2JA.

Link to register: https://www.sharesoc.org/events/sharesoc-growth-company-seminar-in-manchester-19-june-2018/

A copy of the latest investor presentation will be available from 12pm on 15 May 2018 at: http://evgen.com/investors/shareholder-information/

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Evgen Pharma Plc

    More articles like this

    Evgen Pharma Plc

    21 Health Benefits of Broccoli

    Are you looking for a vegetable to spice up your diet in a healthy way? If yes, then broccoli, also called Brassica oleracea italica, is the vegetable you want. The dark green crucifer is not only

    Evgen Pharma Plc

    12 things that are actually tied to breast cancer

    According to the Centres for Disease Control and Prevention (CDC), breast cancer is the most common cancer in women. In the US, one in eight women will develop breast cancer during her lifetime. Those statistics sound

    Evgen Pharma Plc

    10 subtle signs of breast cancer

    A diagnosis of breast cancer can be terrifying. According to the CDC, Breast cancer is the most common cancer in American women of any race or ethnicity. Though the statistics might be scary, catching breast cancer

    Evgen Pharma Plc

    Evgen Pharma plc Investor Presentation in Manchester

    Evgen Pharma plc (LON: EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, announces that Steve Franklin, the Company’s CEO, will be presenting tomorrow evening at a ShareSoc Growth

    Evgen Pharma Plc

    ‘I never knew men could get breast cancer’

    Moses Musonga never thought men could get breast cancer until he was diagnosed with the disease in 2013. The 67-year-old Kenyan told the BBC that he was profoundly shock when doctors told him in 2013 that

    Evgen Pharma Plc

    Male Breast cancer:What are the signs and how to check?

    Breast cancer is more commonly associated with women more than with men, affecting approximately one in eight women in their lifetimes. However, men can still be diagnosed with breast cancer, albeit in far rarer circumstances. While